Olympia Pharmaceuticals, operating as both a 503B FDA-registered outsourcing facility and a 503A compounding pharmacy, has expanded its service offerings to include a wide array of peptide-based therapies. The company provides compounded medications for weight management, longevity, and hormonal health, featuring popular peptides like GLP-1 agonists and regenerative compounds such as BPC-157 and TB-500. Their model emphasizes regulatory compliance, rigorous testing, and nationwide distribution to both clinics and patients.